Sarah Stalnaker

Sarah Stalnaker is an experienced professional in quality management and drug substance quality assurance within the biopharmaceutical industry. Currently serving as Vice President of Global Drug Substance Quality at Moderna since September 2021, Sarah has held multiple key roles, including Global Quality Head for Drug Substance and Raw Materials, and US Quality Head for External Manufacturing and Drug Product. Prior to joining Moderna, Sarah had a notable tenure at Eli Lilly and Company from June 2003 to September 2021, where important positions included Strategic Advisor for Global Quality and Director of Analytical Services, overseeing high-volume quality control testing and supporting various drug formulations through clinical trials. Academic credentials include a Master of Science in Strategic Management and an Executive Certificate in Business - Life Sciences from Indiana University, along with a Bachelor of Science in Chemical Engineering from Rose-Hulman Institute of Technology.